Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence retail sale . Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder function here origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Pharmacotherapeutic group: G04CA01 - alpha-blocker. Side effects and complications in the use of drugs: retail sale decreased libido, reduced ejaculate volume, intensity and increased breast retail sale of hypersensitivity (swelling of the lips, skin rash). Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra here Philadelphia Chromosome bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the retail sale Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, retail sale dose - 1-5 mg and appointed 1 p / day. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Method of production of drugs: Table., Coated tablets, cap. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Method of production of drugs: Table., Coated tablets, 5 mg. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) retail sale seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria retail sale angioedema. Contraindications to the use of drugs: retail sale to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use of drugs: symptomatic treatment of mild dysuria caused retail sale benign prostatic hypertrophy. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and retail sale its fibrosis. Method of production of drugs: Table. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. prolonged, coated tablets, 5 mg, 10 mg. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to night maintenance dose - 5 - 10 mg and appointed 1 p / day. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia.
No comments:
Post a Comment